51 filings
6-K
NYXH
Nyxoah SA
15 Apr 24
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
4:05pm
6-K
NYXH
Nyxoah SA
19 Mar 24
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
4:57pm
6-K
NYXH
Nyxoah SA
5 Mar 24
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
4:13pm
6-K
NYXH
Nyxoah SA
17 Jan 24
Nyxoah Announces 2024 Strategic Priorities
4:12pm
6-K
NYXH
Nyxoah SA
9 Jan 24
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023
5:00pm
6-K
uri2 5rnw
11 Dec 23
Current report (foreign)
4:05pm
6-K
p380h7dct1
8 Nov 23
Nyxoah Reports Third Quarter 2023 Financial and Operating Results
4:24pm
6-K
knf8id3m
29 Sep 23
Nyxoah Announces Partnership with ResMed in Germany
4:05pm
6-K
6weozdfid47yxlv60w
8 Aug 23
Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results
5:56pm
6-K
dhby2is 0ex58
28 Jul 23
Information on the total number of voting rights and shares
3:59pm
6-K
13957tj 5y2kuo5
16 May 23
Nyxoah Reports First Quarter 2023 Financial and Operating Results
4:17pm
6-K
v83jh wywxq8kp41d
15 May 23
Current report (foreign)
4:07pm
6-K
jgpapptimreg
11 May 23
Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer
4:05pm
6-K
runv0dvf
20 Apr 23
Current report (foreign)
5:03pm
6-K
42z 0dfygqbgwpo3igvc
13 Apr 23
Current report (foreign)
4:09pm
6-K
1o5pg2qw
27 Mar 23
Nyxoah Raises $3 Million from an At-the-Market Equity Offering
5:00pm
6-K
vnpyuxqlon oxyee
23 Mar 23
Nyxoah Announces a $15 Million Private Placement Financing
4:28pm
6-K
ioi194pkj8
22 Mar 23
Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:14pm
6-K
vvj44txg
15 Mar 23
Current report (foreign)
4:37pm
6-K
moirl y6q9vymibw
6 Mar 23
Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones
4:57pm